ArticleFrontiers in oncology2026
Association of nasopharynx cancer with obstructive sleep apnea.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Despite the extensive research conducted on the association between OSA and HNCs, the specific relationship between obstructive sleep apnea (OSA) and nasopharyngeal carcinoma (NPC) has received comparatively less attention. The present study aimed to explore the association between OSA and NPC. Methods: The data for this study was drawn from the Longitudinal Health Insurance Database 2010. The study incorporated a total of 3,235 NPC patients and 12,940 propensity score-matched controls. The NPC and controls' baseline clinical and demographic parameters were compared using standardized mean difference. A conditional logistic regression model was developed in order to quantify the association between OSA and the odds of NPC. Results: The prevalence of prior OSA was significantly higher in the NPC group than in the control group (2.07% vs. 1.51%, p = 0.023). Following the adjustment for a comprehensive set of confounders, including age, sex, income, geography, urbanization, diabetes, hypertension, hyperlipidemia, COPD, chronic rhinitis, sinusitis, human papillomavirus infection, tobacco use disorder, and alcohol-related disorders, pre-existing OSA remained associated with an increased odds of developing NPC (adjusted OR = 1.42, 95% CI = 1.07, 1.89). In sex-stratified analysis, the point estimates for the association between OSA and NPC were similar for both males (adjusted OR = 1.41, 95% CI = 1.03, 1.94) and females (adjusted OR = 1.46, 95% CI = 0.77, 2.78). While the association only reached statistical significance in the males, the lack of significance in females may be indicative of lower statistical precision due to the smaller sample size. Conclusion: The present study identifies an association between prior OSA diagnosis and NPC, particularly in the males. Further investigation is required to confirm this relationship and its underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.